Research programme: HIV protease inhibitors - Invenux
Alternative Names: HIV protease inhibitors research programme - InvenuxLatest Information Update: 18 Apr 2005
At a glance
- Originator Invenux (CEASED)
- Class Small molecules
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 31 Dec 2003 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 24 Sep 2002 Preclinical trials in HIV infections treatment in USA (unspecified route)